Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silo Pharma (SILO) Net Income (2019 - 2025)

Silo Pharma's Net Income history spans 7 years, with the latest figure at -$1.1 million for Q3 2025.

  • For Q3 2025, Net Income fell 19.55% year-over-year to -$1.1 million; the TTM value through Sep 2025 reached -$5.1 million, down 36.7%, while the annual FY2024 figure was -$4.4 million, 6211.61% down from the prior year.
  • Net Income for Q3 2025 was -$1.1 million at Silo Pharma, up from -$1.2 million in the prior quarter.
  • Across five years, Net Income topped out at -$1163.0 in Q1 2022 and bottomed at -$1.8 million in Q1 2023.
  • The 5-year median for Net Income is -$930296.5 (2024), against an average of -$797699.1.
  • The largest annual shift saw Net Income soared 98.26% in 2022 before it plummeted 155772.06% in 2023.
  • A 5-year view of Net Income shows it stood at -$256473.0 in 2021, then surged by 99.55% to -$1163.0 in 2022, then tumbled by 90319.26% to -$1.1 million in 2023, then crashed by 64.57% to -$1.7 million in 2024, then skyrocketed by 35.84% to -$1.1 million in 2025.
  • Per Business Quant, the three most recent readings for SILO's Net Income are -$1.1 million (Q3 2025), -$1.2 million (Q2 2025), and -$1.0 million (Q1 2025).